Literature DB >> 3986859

Effect of aspirin and indomethacin on exercise-induced changes in blood pressure and limb blood flow in normal volunteers.

A J Cowley, K Stainer, J M Rowley, R G Wilcox.   

Abstract

To evaluate the possible role of prostaglandins in exercise-induced changes in blood pressure and limb blood flow we have compared the effects of aspirin and indomethacin in a double-blind placebo controlled study in a group of normal volunteers. Nine men undertook treadmill exercise after pretreatment with placebo, aspirin and indomethacin. Indomethacin caused a greater increase in systolic blood pressure during exercise than aspirin (p less than 0.05) and a smaller fall in diastolic pressure than either placebo or aspirin (p less than 0.02 and p less than 0.01). Compared with placebo both aspirin and indomethacin attenuated to a similar degree the increase in calf blood flow (p less than 0.05 and p less than 0.03) and the changes in forearm blood flow following exercise. These results suggest that although aspirin and indomethacin both inhibit prostaglandin production they have different effects on exercise-induced changes in blood pressure. They have, however, similar effects on limb blood flow.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3986859     DOI: 10.1093/cvr/19.3.177

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  11 in total

Review 1.  Control of skeletal muscle blood flow during dynamic exercise: contribution of endothelium-derived nitric oxide.

Authors:  D J Green; G O'Driscoll; B A Blanksby; R R Taylor
Journal:  Sports Med       Date:  1996-02       Impact factor: 11.136

Review 2.  NSAIDs and blood pressure. Clinical importance for older patients.

Authors:  A G Johnson
Journal:  Drugs Aging       Date:  1998-01       Impact factor: 3.923

Review 3.  Exercise blood pressure: clinical relevance and correct measurement.

Authors:  J E Sharman; A LaGerche
Journal:  J Hum Hypertens       Date:  2014-10-02       Impact factor: 3.012

4.  Effects of L-arginine supplementation on blood flow, oxidative stress status and exercise responses in young adults with uncomplicated type I diabetes.

Authors:  Ana Paula Trussardi Fayh; Mauricio Krause; Josianne Rodrigues-Krause; Jerri Luiz Ribeiro; Jorge Pinto Ribeiro; Rogério Friedman; José Cláudio Fonseca Moreira; Alvaro Reischak-Oliveira
Journal:  Eur J Nutr       Date:  2012-07-06       Impact factor: 5.614

Review 5.  NSAIDs and increased blood pressure. What is the clinical significance?

Authors:  A G Johnson
Journal:  Drug Saf       Date:  1997-11       Impact factor: 5.606

Review 6.  Nonsteroidal anti-inflammatory drugs and hypertension. The risks in perspective.

Authors:  P W de Leeuw
Journal:  Drugs       Date:  1996-02       Impact factor: 9.546

7.  Prostaglandins induce vasodilatation of the microvasculature during muscle contraction and induce vasodilatation independent of adenosine.

Authors:  Coral L Murrant; Jason D Dodd; Andrew J Foster; Kristin A Inch; Fiona R Muckle; Della A Ruiz; Jeremy A Simpson; Jordan H P Scholl
Journal:  J Physiol       Date:  2014-01-27       Impact factor: 5.182

Review 8.  Contribution of non-endothelium-dependent substances to exercise hyperaemia: are they O(2) dependent?

Authors:  Janice M Marshall; Clare J Ray
Journal:  J Physiol       Date:  2012-10-08       Impact factor: 5.182

9.  Extracellular matrix fibronectin initiates endothelium-dependent arteriolar dilatation via the heparin-binding, matricryptic RWRPK sequence of the first type III repeat of fibrillar fibronectin.

Authors:  Ingrid H Sarelius; Patricia A Titus; Nir Maimon; William Okech; Susan J Wilke-Mounts; James R Brennan; Denise C Hocking
Journal:  J Physiol       Date:  2016-01-15       Impact factor: 5.182

10.  Amino acid supplementation and impact on immune function in the context of exercise.

Authors:  Vinicius Fernandes Cruzat; Maurício Krause; Philip Newsholme
Journal:  J Int Soc Sports Nutr       Date:  2014-12-14       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.